Further, we observed a close negative association between the pattern of [18F]SynVesT-1 and tau PET in patients with varied phenotypic presentations of AD, as well as a negative association between global SV2A density and Aβ burden. The gene discussed is MAPT; the disease is Alzheimer disease.